Arcadia Biosciences, Inc. (RKDA) Free cash flow 2017–2026
Arcadia Biosciences, Inc. (RKDA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$4.7MFY2026 · since FY2017: -$17.3M → -$4.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$4.7M | +51.3% |
| FY2025 | -$9.6M | +37.0% |
| FY2024 | -$15.3M | -8.9% |
| FY2023 | -$14.0M | +47.7% |
| FY2022 | -$26.9M | +17.4% |
| FY2021 | -$32.6M | -74.3% |
| FY2020 | -$18.7M | -34.5% |
| FY2019 | -$13.9M | +1.2% |
| FY2018 | -$14.0M | +18.8% |
| FY2017 | -$17.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice